Uveitis associated with rifabutin therapy: a clinical alert.
BACKGROUND
The incidence of Mycobacterium avium complex (MAC) infection is increasing among patients with AIDS. Rifabutin therapy has been demonstrated to be effective in the treatment and prophylaxis of MAC infection. over the past 3 years there have been several reports of uveitis associated with rifabutin therapy. The uveitis is almost always interior, begins unilaterally and progresses to involve both eyes. There is almost always a hypopyon present, and the uveitis progresses aggressively. It responds well to conventional treatment along with the discontinuance of rifabutin.


RESULTS
This paper presents a new case of rifabutin uveitis and a review of the various published reports to date.


CONCLUSIONS
All primary eye care clinicians should be aware of this new and unique clinical presentation and be prepared to recognize it quickly and treat it appropriately.
Petrowski
J T
JT
Lahey-Hitchcock Clinic, Lebanon, NH 03756, USA.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000904:Antibiotics, Antitubercular / Q000009:adverse effects* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D017828:Rifabutin / Q000009:adverse effects* / Q000627:therapeutic use; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000473:pathology; D014792:Visual Acuity
D000904:Antibiotics, Antitubercular; D017828:Rifabutin